While CBD is known for its relaxing effects without being psychoactive, HHC (hexahydrocannabinol) is a lesser-known molecule that can induce psychotropic effects. Let’s delve into the differences between these two substances from the same family, but with contrasting properties. CBD’s properties: relaxation without altered perception CBD (cannabidiol), extracted from the hemp plant, is known and appreciated for its numerous benefits to the body, including:
Analgesic effects: pain relief
Anti-inflammatory effects: reduction of inflammation and redness
- Reduction of anxiety and stress
- Improved sleep
- Support for the immune system
- Unlike THC (tetrahydrocannabinol), the main active agent in cannabis which causes feelings of euphoria and intoxication, CBD does not alter the consciousness or perception of users,
- hence its legalization in many countries, including France. HHC, a cousin of THC with psychotropic effects
Unlike CBD, HHC is known for its potency, due to its psychoactive effects. Unlike CBD, HHC can produce sensations similar to consuming THC,
the active ingredient in a traditional joint.
Because of these effects, French authorities have decided to classify HHC as a narcotic. Unlike CBD, which does not alter perception or consciousness, HHC can temporarily alter an individual’s mental state. Therefore, the French National Agency for Medicines and Health Products Safety (ANSM) reacted by classifying it as a narcotic, thus prohibiting all forms of marketing and consumption in France.
Detection of HHC in bodily fluids
HHC can indeed be detected in bodily fluids, including saliva, generally during tests designed to detect the presence of THC. Although it is a distinct molecule,
Current tests are accurate enough to identify HHC in blood and saliva using specific markers. HHC’s legal status: classified as a narcotic since 2023
Since June 13, 2023, HHC has been legally recognized as a narcotic in France. This decision, applauded by the Minister of Health, resulted from the classification by the ANSM (French National Agency for Medicines and Health Products Safety), thus addressing growing concerns about the effects of this substance. As a result,
the production, marketing, and use of HHC are now prohibited. Other cannabinoid substances under study
In addition to CBD and HHC, other substances such as CBG (cannabigerol) and variations like H4CBD are also generating interest. Each cannabinoid has distinct properties:
- Some, like CBD, are legal and valued for their benefits without psychotropic effects.
Others, like HHC, present potential risks leading to legal restrictions.
